top of page

Groups Feed

View groups and posts below.


This post is from a suggested group

Hunter Syndrome treatment focuses on managing symptoms, slowing disease progression, and improving patients’ quality of life, as there is currently no complete cure. The primary medical approach involves enzyme replacement therapy (ERT) with idursulfase, which helps compensate for the missing iduronate-2-sulfatase enzyme responsible for breaking down glycosaminoglycans (GAGs). ERT can reduce organ enlargement, improve respiratory function, and enhance mobility, although it has limited effect on neurological symptoms due to its inability to cross the blood–brain barrier. In addition, supportive treatments—such as physical therapy, respiratory care, cardiac monitoring, and surgical interventions for hearing loss or airway obstruction—play a crucial role in long-term management.

Innovations in gene therapy and intrathecal treatments are emerging as promising options for addressing cognitive decline and neurological complications. These advanced therapies aim to deliver the enzyme directly to the central nervous system or modify the patient’s genetic makeup to enable sustained enzyme production. Although still under clinical evaluation, early-stage studies show potential for improved cognitive outcomes and slower neurological deterioration. As research advances, the combination of targeted genetic therapies, optimized ERT, and comprehensive supportive care is expected to significantly improve survival rates and overall quality of life for individuals living with Hunter Syndrome.

View More Trending Title-

https://www.emergenresearch.com/industry-report/hydrogen-fuel-cell-market

https://www.emergenresearch.com/industry-report/intelligent-materials-market

https://www.emergenresearch.com/industry-report/low-carbon-flooring-market

https://www.emergenresearch.com/industry-report/marine-biofuel-market

https://www.emergenresearch.com/industry-report/minimally-invasive-thoracic-surgery-market

 

This post is from a suggested group

2 Views

Talenbrium is a forward-thinking HR consulting firm that empowers organizations with data-driven talent intelligence. Combining big-data analytics, AI and machine learning, the platform offers deep insights — from global talent pools and skill-set trends to city-level hiring dynamics and salary benchmarks.

Serving industries such as IT, BFSI, healthcare, chemicals, oil & gas and medical devices, Talenbrium helps HR leaders make smarter decisions around workforce planning, recruitment, and development. By analysing global hiring trends, skill gaps, and diverse talent profiles, it supports companies in building a more efficient, inclusive, and future-ready workforce.

At its core, Talenbrium’s AI-powered dashboard delivers predictive recommendations, natural language processing insights, and continuous learning capabilities — helping organizations strategize talent acquisition, reduce turnover, cut hiring costs, and gain a competitive edge.

Whether through bespoke executive reports, custom research, or advisory services, Talenbrium enables HR teams to harness real-time market intelligence and optimise their global talent strategy with clarity and confidence.

Look Out: https://www.talenbrium.com/off-the-shelf-report

This post is from a suggested group

Enhancing Patient Safety and Resource Utilization Through Strategic Interventions in the Patient Blood Management Market

The Patient Blood Management (PBM) Market is driven by a multidisciplinary, evidence-based approach designed to optimize the care of patients who might need a blood transfusion. PBM programs aim to reduce the need for transfusions by treating anemia, minimizing blood loss, and harnessing the patient's own physiological reserves, thereby conserving blood supplies and improving patient outcomes. This shift is critical because blood transfusions, while often lifesaving, are associated with risks, including immunological reactions, infections, and even increased mortality in certain contexts. The PBM market includes diagnostic tests for anemia and coagulopathy, software for clinical decision support, and devices for intraoperative blood salvage. The economic argument for PBM is compelling: by reducing transfusion rates, hospitals save money on procurement, testing, storage, and handling of blood products, while also lowering the cost of treating transfusion-related adverse events.…


2 Views

This post is from a suggested group

1 View

This post is from a suggested group

Wyld Rose Holistics 🌹
April 2, 2023 · updated the description of the group.


ree

This post is from a suggested group

Welcome to the group! You can connect with other members, get updates and share photos.

Wyld Rose Holistics emerged out of our passion for natural essential oils, natural creamy butters and botanical's and the health and well being properties they provide us.

From making our products in our workshop to the manufacturers we choose, we continue to inspire change when creating beautiful products for our customers. Sustainability for the health of everyone and the planet is very important to us.

 

This combined with a fascination for Traditional Cold-process soap making techniques, our love of Eastern travel, colour, casting, shape, pattern and print our business began...read [..]

If you would like to receive updates on our progress and special offers, please leave your email below, Thank you

  • Etsy
  • Twitter
  • Pinterest
  • Facebook
  • Amazon
  • Instagram
01-3-18-3744_edited_edited.

© 2016 by Wyld Rose Holistics 

bottom of page